APOE4 Prevention Protocol
Evidence-graded health synthesis. Enter hub password to continue.
That's not right. Try again.
🧬 Evidence-Graded Health Protocol
APOE4 Alzheimer's-Prevention Protocol
← Back to Hub
Read This First
Disclaimer + Legend This is not medical advice. Nothing here replaces a conversation with your own doctor. This pulls together one creator's recommendations and grades each one by how strong the evidence really is. Several items below are prescription-only or still in clinical trials, and a few are tied to products the presenter sells. Bring this list to a physician who knows your full history.
Synthesized from the Kevin Tran APOE4 Protocol notebook, 81 sources, June 2026. One creator's content, evidence-graded. Not medical advice.
🟢 STRONGbacked by randomized controlled trials or solid human evidence.
🟡 MODERATEconsistent observational data, or a solid mechanism plus some human data.
🟠 PRELIMINARYmostly mechanism, animal studies, or early human work. Plausible but unproven.
🔴 SPECULATIVE / CONFLICTEDweak evidence, and/or tied to a product the presenter sells or earns from.
Foundation (do-now, well-supported)
Start hereThese are the 🟢 and 🟡 items. If you do nothing else, start here. They're the strongest-evidence, lowest-risk moves, and most are things you can begin this week without a prescription.
Diet
- Eat a Mediterranean / MIND diet: extra-virgin olive oil as your main fat, fatty fish, legumes, leafy greens, nuts. Limit pastries, butter, cheese. (35% lower dementia risk in APOE4/4 carriers in a 34-year cohort.)
- Eat fats and protein first, complex carbs last at every meal to blunt glucose spikes.
- Add soluble fiber (about 5g psyllium husk before meals, 30g total fiber daily). Lowers cholesterol and improves insulin sensitivity (29-RCT meta-analysis).
- Cut added sugar, refined carbs, and liquid calories (soda, juice, sweets).
- Avoid processed meats (bacon, hot dogs, deli meat).
- Keep saturated fat low (butter, cheese, coconut oil, fatty red meat). Carriers are hyper-responders.
- Cut alcohol to near-zero. In carriers, even 1-2 drinks/day doubled cognitive-impairment risk over 35 years.
Supplements
- B-vitamins (methylfolate, methyl-B12, P5P/B6) to lower homocysteine. Cut brain shrinkage 53% in people with high homocysteine, but only when omega-3 was also adequate (VITACOG RCT).
- Vitamin D3 (+K2), 2,000-5,000 IU/day, target 50-80 ng/mL.
- Magnesium (L-threonate or glycinate) at bedtime for deeper sleep.
- Phospholipid omega-3 (krill oil, fish roe, or LPC-DHA) rather than plain fish oil. Standard fish oil reaches the APOE4 brain about 59% less well.
- Ashwagandha (300-600mg) for stress/cortisol if stress is an issue (RCT: cortisol down ~33%).
Exercise
- Zone 2 cardio, 150-240 min/week. Raised hippocampal blood flow specifically in carriers.
- HIIT, 1-2 short sessions/week. Carriers need the intensity to trigger BDNF.
- Strength training, 2-3x/week, for insulin sensitivity and lean mass.
- Sauna, 4-7x/week (Finnish dry heat, 15-20 min). 65% lower Alzheimer's risk over 20 years (observational).
Sleep & lifestyle
- Cognitive + social engagement (learn skills, stay social, complex hobbies). Carriers got 2.6x more benefit than non-carriers in the FINGER trial. This is the single best-proven lifestyle lever here.
- Strict sleep consistency, 7-9 hours, cool dark room, same bed/wake time. Poor sleep plus APOE4 = 5.6x dementia risk.
- Morning + evening sunlight; block blue light at night.
- Meditation or 4-7-8 breathwork daily. 2024 data: mindfulness protected carriers specifically.
Labs to track (mostly self-orderable)
- ApoB (target <70), Lp(a), LDL-P: carriers clear LDL poorly, so standard "normal" isn't good enough.
- hs-CRP (target <1): a "normal" CRP up to 3 still meant 6.6x higher risk in carriers.
- Fasting insulin, glucose, HbA1c, HOMA-IR: the APOE4 brain can starve even when these look okay.
- Homocysteine (target <10, ideally 6-7).
- Omega-3 Index (target 10-12%).
- p-tau217 (target <0.3): 94-97% accurate, rises 15-20 years before symptoms. Retest annually after 50.
- Sleep apnea screen if you snore. 75% of memory-clinic patients have undiagnosed apnea.
Full Protocol: Diet
Evidence-graded| Action | Dose / detail | Mechanism | APOE4-specific? | Tier | Note |
|---|---|---|---|---|---|
| Mediterranean / MIND diet | Olive oil, fish, legumes, greens, nuts; limit sweets/butter/cheese | Lowers inflammation and oxidative stress, slows gray-matter loss | Yes (35% vs 5% risk drop) | 🟡 MODERATE | Big observational cohorts, not RCTs, but very consistent. |
| Fats/protein first, carbs last | Every meal | Smaller glucose and insulin spikes | Relevant | 🟡 MODERATE | Simple, free, well-grounded mechanism. |
| Soluble fiber / psyllium | 5g before meals, 30g/day total | Binds gut cholesterol, improves insulin sensitivity | Relevant | 🟢 STRONG | 29-RCT meta-analysis. |
| Cut added sugar / refined carbs | Near zero | Avoids insulin resistance and AGEs | Yes ("Type 3 diabetes" brain) | 🟡 MODERATE | Strong rationale; effect size on dementia is inferred. |
| Avoid processed meats | Zero | Inflammation, dementia risk | No (+14% for everyone) | 🟡 MODERATE | Broad observational consensus. |
| Keep saturated fat low | Under ~5-6% of calories | Raises LDL; lipid pileup in microglia | Yes (carriers are hyper-responders) | 🟡 MODERATE | Carrier-specific decline data is observational. |
| Cut alcohol | Zero, or 1-2 drinks/month max | Damages blood-brain barrier, wrecks REM, blocks glymphatic clearance | Yes (synergistic toxicity) | 🟡 MODERATE | Honolulu-Asia Aging Study, 35 years, carriers only. |
| Eat unprocessed meat/poultry | Lean cuts | B12, iron, creatine | Yes (55% lower risk, carriers only) | 🟠 PRELIMINARY | One 2026 cohort; strong reverse-causation risk (sick people stop cooking). |
Full Protocol: Supplements
Evidence-graded| Action | Dose / detail | Mechanism | APOE4-specific? | Tier | Note |
|---|---|---|---|---|---|
| B-vitamins (methylfolate, B12, B6) | 0.8mg folate, 0.5mg B12, 20-50mg P5P | Lowers homocysteine, cuts brain atrophy | Yes | 🟢 STRONG | VITACOG RCT (53% less atrophy), but only works with adequate omega-3. |
| Vitamin D3 (+K2) | 2,000-5,000 IU, target 50-80 ng/mL | Anti-inflammatory, supports BBB | Yes | 🟡 MODERATE | Strong rationale; correcting a deficiency is sensible. |
| Magnesium (threonate/glycinate) | 1g threonate or 200-400mg glycinate at night | Better deep/REM sleep | Relevant | 🟡 MODERATE | Targets a real APOE4 sleep deficit. |
| Phospholipid omega-3 (krill/LPC-DHA) | 1-2g/day with fat; fish roe 3-4x/week | Crosses BBB via MFSD2A, bypassing the leaky barrier | Yes (59% less plain DHA reaches carrier brains) | 🟠 PRELIMINARY | Mechanism is solid; plain fish-oil RCTs largely failed. Form matters. |
| Ashwagandha | 300-600mg with food | Lowers cortisol (~33%) | Yes (cortisol drives amyloid in carriers) | 🟡 MODERATE | RCT-backed for stress, not APOE4-specific. |
| Souvenaid (Fortasyn Connect) | Daily medical food | Uridine/choline/DHA/B for synapse repair | Compensates carrier deficit | 🟡 MODERATE | Some RCT support in early disease. |
| C8 MCT oil / exogenous ketones | Build to 15-20g/day | Raises blood ketones for brain fuel | Yes (bypasses glucose deficit) | 🟠 PRELIMINARY | Real ketone effect; cognitive benefit unproven, the big keto RCT failed. |
| Melatonin | 1-3mg, 30 min before bed | Circadian alignment | Carriers have ~half the CSF melatonin | 🟠 PRELIMINARY | Reasonable for sleep/jet lag. |
| Lithium (microdose) | Trace daily | Neuroprotection | Broad 40% risk drop | 🟠 PRELIMINARY | Intriguing observational signal; dosing unstandardized. |
| Sulforaphane (broccoli sprouts) | 30-40mg/day | Inhibits MMP9 (protects BBB) | Yes | 🔴 SPECULATIVE | Mechanistic only; part of presenter's supplement-stack funnel. |
| Curcumin (+piperine) | 500mg-1g/day | Inhibits cPLA2 inflammation | Yes | 🔴 SPECULATIVE | Mechanistic; stack item. |
| NAC / NACET | 600-1200mg | Replenishes glutathione | Yes (blocks alcohol-APOE4 toxicity) | 🔴 SPECULATIVE | Mechanistic; stack item. |
| CD38 inhibitors (quercetin, apigenin) | Diet / chamomile tea | Preserves NAD+ | Yes | 🔴 SPECULATIVE | Mechanistic; safer than NMN/NR but unproven. |
Full Protocol: Exercise
Evidence-graded| Action | Dose / detail | Mechanism | APOE4-specific? | Tier | Note |
|---|---|---|---|---|---|
| Zone 2 cardio | 150-240 min/week, 3-4 sessions | Builds hippocampal mitochondria, blood flow | Yes (flow rose only in carriers) | 🟢 STRONG | Human imaging + broad exercise RCT base. |
| HIIT | 1-2 sessions, 15-20 min/week | Spikes BDNF | Yes (carriers need intensity) | 🟡 MODERATE | Good mechanistic + human data. |
| Strength training | 2-3x/week | Insulin sensitivity, lean mass, NAD+ | Compensates insulin resistance | 🟢 STRONG | Strong general evidence base. |
| Finnish sauna | 80-95°C, 15-20 min, 4-7x/week | Heat-shock proteins, BDNF +66% | Compensates protein-clearance deficit | 🟡 MODERATE | Kuopio study, 20 years, 65% risk drop (observational). |
| Cold exposure / plunge | 50-60°F, 3-5 min, 3-4x/week | Brown-fat glucose sink, lowers IL-6 | Targets glucose + inflammation | 🟠 PRELIMINARY | Mouse + small human physiology studies. |
Full Protocol: Sleep & Lifestyle
Evidence-graded| Action | Dose / detail | Mechanism | APOE4-specific? | Tier | Note |
|---|---|---|---|---|---|
| Cognitive + social engagement (FINGER) | Daily, ongoing | Builds cognitive reserve | Yes (2.6x more benefit) | 🟢 STRONG | FINGER RCT subgroup. Best-proven item here. |
| Sleep consistency / hygiene | 7-9 hrs, 60-67°F, fixed times | Boosts glymphatic clearance | Yes (5.6x risk with bad sleep) | 🟡 MODERATE | Strong human observational + mechanism. |
| Light exposure management | AM/PM sunlight; block blue light | Sets circadian clock | Re-regulates carrier sleep | 🟡 MODERATE | Well-established circadian science. |
| Meditation / 4-7-8 breathwork | 20 min/day | Parasympathetic shift, lowers cortisol | Yes (2024 carrier data) | 🟡 MODERATE | Promising carrier-specific signal. |
| Lateral side-sleeping | Nightly, body pillow | 2.2x more glymphatic clearance | Yes (broken glymphatic system) | 🟠 PRELIMINARY | Rat MRI study; human data thin. |
| Acoustic stimulation / pink noise | Nightly headband | Boosts slow-wave sleep 17.7% | Compensates deep-sleep deficit | 🟠 PRELIMINARY | Small human studies; device-based. |
| Photobiomodulation (1070nm red light) | 10-20 min/day, helmet | Mitochondrial ATP, less inflammation | Compensates microglial burnout | 🔴 SPECULATIVE | Mostly mouse 40Hz data; presenter sells via affiliate ($1,795 helmet). |
| Vagus-nerve stimulation (VNS) | Ear device before bed | Raises HRV, parasympathetic | Combats carrier hyper-vigilance | 🔴 SPECULATIVE | Early pilots; presenter runs paid community device study. |
Discuss With Your Doctor (Medical & HRT)
Prescription / in-trialNone of these are DIY. Bring this list to a physician who knows your full history.
Available by prescription (off-label or standard)
- Statins (rosuvastatin/atorvastatin, low dose). 🟡 MODERATE. 40% lower Alzheimer's risk in carriers specifically (5-year observational + genetic data).
- Ezetimibe (10mg). 🟡 MODERATE. Genetic (Mendelian) data suggests up to 80% lower dementia risk from lifelong cholesterol-absorption blockade. The 7-fold observational figure is heavily confounded.
- Bempedoic acid / PCSK9 inhibitors. 🟠 PRELIMINARY. Add-ons to hit aggressive ApoB targets.
- SGLT2 inhibitors (dapagliflozin, empagliflozin). 🟠 PRELIMINARY for brain; bypasses brain glucose resistance.
- DORA sleep meds (suvorexant, lemborexant). 🟢 STRONG mechanism: cut CSF tau/amyloid within 36 hours in human studies. Far safer than Benadryl-type sleep aids, which worsen dementia.
- Low-dose doxycycline (off-label, 20-30mg). 🟠 PRELIMINARY. MMP9 inhibitor to protect the BBB.
- Rapamycin (off-label, cyclic). 🟠 PRELIMINARY. Autophagy via mTOR; observational carrier signal only. Real immune-suppression risks.
- Ketorolac (off-label NSAID). 🟠 PRELIMINARY. Microglial inflammation target.
Women's HRT
- Transdermal estradiol + micronized progesterone (never synthetic Provera/MPA). 🟡 MODERATE. Start in the "critical window" (during or within 3-5 years of menopause). Whitmer 2011 showed 26% lower risk if started early vs 48% higher if started late. The small KEEPS imaging RCT showed the patch reduced amyloid in carriers. Timing is everything.
Men, a caution
- TRT + aromatase inhibitors. 🟡 MODERATE caution. Carrier men on TRT showed worse cognition, and blocking estrogen conversion (with anastrozole) removes a protective pathway. Flag this with your doctor.
Still in clinical trials (not yet available)
- Obicetrapib (CETP inhibitor). 🟢 STRONG signal. Phase 3 sub-study: 20.5% drop in p-tau217 in APOE4/4 homozygotes.
- Valiltramiprosate (ALZ-801). 🟡 MODERATE, with a caveat: the Phase 3 trial missed its primary endpoint. The celebrated hippocampal-preservation results are secondary findings. Zero brain-bleed (ARIA) risk is a real plus.
- Buntanetab. 🟡 MODERATE. Phase 2/3 cognitive improvement + lower NfL, carriers and non-carriers alike, no ARIA.
- Mirodenafil (PDE5 inhibitor). 🟠 PRELIMINARY. Restores Claudin-5 to repair the BBB (mouse data).
Treat With Skepticism (hype / commercially conflicted)
Conflict of interestThese items lean on weak evidence, the presenter's own opinion, or a product he profits from. They aren't necessarily wrong, but the conflict of interest is real, so weigh them accordingly and don't pay premium prices on this evidence alone.
- The "Phoenix Community" paid app and subscription. The channel funnels viewers into a paid membership for biomarker tracking and "n=1 experiments." A credibility audit notes the presenter equates unblinded, self-reported app data with "clinical-trial quality." It isn't.
- The 15+ supplement stack as a bundle (lithium, NAC, curcumin, sulforaphane, C8 MCT, etc.). Individual compounds have mechanistic backing, but stacking them all has zero clinical validation and is used to drive subscriptions.
- Neuronic red-light helmet ($1,795) sold with the presenter's affiliate code. Evidence is largely extrapolated from mouse 40Hz studies.
- Sens.ai neurofeedback headset ($1,150 + monthly fee) promoted with his link.
- BrainBit EEG headband ($499-$750) with a "special program" for paid members.
- Xenawell/Zeno vagus-nerve stimulator, sold through a community study.
- Oura Ring / Whoop pitched as "gold standard" trackers (useful, but heavily promoted).
- Accentrate Omega Max omega-3 with a 20%-off affiliate code.
- Nucleus/MyNucleus genome sequencing ($499 + $39/yr) with a promo code.
- Preceze cognitive app, ProLon fasting kits, private coaching/concierge consults, and recommended pharmacies and lab services (Canadian online pharmacy, Ulta Labs, Fullscript) where the presenter or his collaborators have a commercial relationship.
The pattern: the strongest-evidence items (diet, exercise, sleep, B-vitamins, lipid management, the FINGER lifestyle bundle) cost little or nothing. The expensive branded devices and the paid community sit at the weakest-evidence end. That's worth remembering.
Where to Get p-tau217 Tested (Boulder, CO)
Local lab guidep-tau217 is the single best blood biomarker for tracking Alzheimer's pathology, and it's the one lab to baseline and re-check over time. Here's where to get it done in Boulder, what it costs, and how accurate each option is. Note: these tests were validated in people who already have cognitive symptoms, so using one as proactive screening is off-label, insurance usually won't cover it, and a positive result is best interpreted with a provider.
Most accurate (2026)
The ratio tests (%p-tau217 + amyloid) beat standalone p-tau217. Two co-leaders: C2N PrecivityAD2 (%p-tau217 + amyloid ratio, AUC 0.95, ~91% accurate vs PET, deepest validation) and Fujirebio Lumipulse pTau217/Abeta42 (the only FDA-cleared AD blood test, May 2025, 97% NPV, now run by Labcorp). Standalone p-tau217 (Quest AD-Detect, Labcorp 484390) is a notch below but solid, and the Quest one needs no doctor.
| Test | Accuracy | Needs doctor? | Boulder draw site | Cost (cash) | Turnaround |
|---|---|---|---|---|---|
| Quest AD-Detect p-tau217 (DTC) | Good (standalone) | No (orders online, physician sign-off included) | Quest, 2798 Arapahoe Ave, Boulder | ~$412 ($399 + $13 fee) | ~5 to 10 business days (confirm) |
| Lumipulse pTau217/Abeta42 via Labcorp | Highest, FDA-cleared, 97% NPV | Yes | Labcorp, 2750 Broadway St, Boulder | ~$626 (confirm) | ~5 to 7 days |
| C2N PrecivityAD2 (%p-tau217 ratio) | Highest, AUC 0.95 | Yes | Quest or Labcorp Boulder (kit shipped) | ~$1,450 (confirm w/ C2N) | within 10 business days |
| Labcorp standalone pTau-217 (484390) | Good (standalone) | Yes | Labcorp, 2750 Broadway St, Boulder | ~$626 list (confirm) | 5 to 7 days |
Boulder draw sites
- Quest Diagnostics, 2798 Arapahoe Ave, Boulder, CO 80302, (303) 328-1952
- Labcorp, 2750 Broadway St, Boulder, CO 80304, (303) 442-1862
(Call to confirm current hours.)
My recommendation
Start cheap and frictionless: Quest AD-Detect (~$412). Order at questhealth.com (independent physician signs off, no doctor needed), draw at the Arapahoe Quest, results in about a week. For tracking a trend over time, a consistent single biomarker on the same platform is genuinely useful. If a result comes back elevated or borderline, escalate to the FDA-cleared Lumipulse ratio (Labcorp, ~$626) or PrecivityAD2 (~$1,450) with a provider who can interpret it.
Confirm by phone
PrecivityAD2 exact price (C2N 1-877-226-3424), Quest AD-Detect turnaround (questhealth.com checkout), Labcorp pricing/coverage, and current lab hours.
Synthesized from the Kevin Tran APOE4 Protocol notebook, 81 sources · June 2026 · Private · ← Hub